accuRx, a London, UK-based healthcare platform, raised £27.5 million in Series B funding led by Lakestar.
British Patient Capital, Latitude VS (sister fund to London-based seed investor LocalGlobe), Atomico, Trusted Insight, and Encore Capital also participated in the round.
The newly raised funds will facilitate the growth of the team, enhancing its offering to GP practices and building products that will enable expansion into secondary care.
Company: AccuRx Limited
Round: Series B
Funding Month: September 2021
Lead Investors: Lakestar
Additional Investors: British Patient Capital, Latitude VS, Atomico, Trusted Insight, and Encore Capital
Company Website: http://www.accurx.com/
Software Category: Healthcare platform
About the Company: Led by Jacob Haddad, CEO, and Laurence Bargery, CTO, accuRx offers a collaborative communications platform that brings patients and their healthcare teams together. It allows existing health and care systems to deliver technology-enabled care, beginning with the National Health Service (NHS) in the UK. The software is currently used by 98% of GP practices in England and a growing number of hospitals and community trusts to communicate with their patients and one another.